Table 1.
Baseline characteristics of two PD management models.
| Total n = 190 |
Conventional management n = 100 |
FCH three-level management n = 90 |
p | |
|---|---|---|---|---|
| Male, n (%) | 105 (55.3) | 60(60.0) | 45(50.0) | 0.166 |
| Age (years) | 65.7 ± 13.4 | 65.5 ± 13.3 | 65.8 ± 13.6 | 0.877 |
| BMI (kg/m2) | 23.1 ± 3.2 | 23.4 ± 3.5 | 22.7 ± 2.8 | 0.126 |
| SBP(mmHg) | 147.5 ± 22.1 | 147.0 ± 22.7 | 148.0 ± 21.6 | 0.742 |
| DBP(mmHg) | 81.0 ± 12.9 | 80.2 ± 12.8 | 81.9 ± 13.1 | 0.378 |
| Education, n (%) | 0.129 | |||
| Illiteracy | 36 (19.0) | 14 (14.0) | 22 (24.7) | |
| Primary school | 60 (31.7) | 30 (30.0) | 30 (33.7) | |
| Junior high school | 66 (34.9) | 40 (40.0) | 26 (29.2) | |
| Senior high school | 21 (11.1) | 14 (14.0) | 7 (7.9) | |
| Undergraduate | 6 (3.2) | 2 (2.0) | 4 (4.5) | |
| Cause of ESRD, n (%) | <0.001 | |||
| Hypertensive nephropathy | 32 (16.8) | 26 (26.0) | 6 (6.7) | |
| Diabetic nephropathy | 51 (26.8) | 36 (36.0) | 15 (16.7) | |
| Glomerulonephritis | 95 (50.0) | 29 (29.0) | 66 (73.3) | |
| Hyperuricemic nephropathy | 3 (1.6) | 0 (0.0) | 3 (3.3) | |
| Other | 9 (4.7) | 9 (9.0) | 0 (0.0) | |
| Complication, n (%) | ||||
| Hypertension | 187 (98.4) | 98 (98.0) | 89 (98.9) | 0.624 |
| Diabetes mellitus | 78 (41.1) | 49 (49.0) | 29 (32.2) | 0.019 |
| Dyslipidemia | 78 (41.1) | 52 (52.0) | 26 (28.9) | 0.001 |
| Cardiovascular disease | 62 (32.6) | 34 (34.0) | 28 (31.1) | 0.672 |
| Cerebrovascular disease | 26 (13.7) | 18 (18.0) | 8 (8.9) | 0.068 |
| Medications n(%) | ||||
| CCB | 152 (80.0) | 78 (78.0) | 74 (82.2) | 0.468 |
| ARB/ACEI | 126 (66.3) | 68 (68.0) | 58 (64.4) | 0.605 |
| Lipid-lowering medications | 67 (35.3) | 44 (44.0) | 23 (25.6) | 0.008 |
| Anti-diabetic medications | 10 (5.3) | 4 (4.0) | 6 (6.7) | 0.430 |
| Insulin | 47 (24.7) | 31 (31.0) | 16 (17.8) | 0.035 |
| Antiplatelet medications | 47 (24.7) | 29 (29.0) | 18 (20.0) | 0.151 |
| Calcitriol | 43 (22.6) | 20 (20) | 23 (25.6) | 0.361 |
PD: peritoneal dialysis; FCH: Family-Community-Hospital; BMI: body mass index; SBP: systolic blood pressure, DBP: diastolic blood pressure; ESRD: end-stage renal disease; CCB: calcium channel blocker; ARB/ACEI: angiotensin receptor blocker/angiotensin converting enzyme inhibitors. Other reasons for ESRD included IgA nephropathy, polycystic kidney, obstructive nephropathy.